Amel Kime, Guillaume Bataillon, Isabelle Treilleux, Céline Callens, Frédéric Selle, F. Heitz, S. Cinieri, Antonio González-Martín, Gerhard Bogner, Gabriel Lindahl, Gabriella Parma, I. Vergote, Takashi Matsumoto, C. Blonz, U. Canzler, A. Mosconi, Eric Pujade-Lauraine, C. Genestie, I. Ray-Coquard, P. Just
{"title":"368 形态学和免疫浸润能否预测新诊断的高级别浆液性卵巢癌的 HRD 状态?GINECO研究PAOLA-1/ENGOT-Ov25试验的启示","authors":"Amel Kime, Guillaume Bataillon, Isabelle Treilleux, Céline Callens, Frédéric Selle, F. Heitz, S. Cinieri, Antonio González-Martín, Gerhard Bogner, Gabriel Lindahl, Gabriella Parma, I. Vergote, Takashi Matsumoto, C. Blonz, U. Canzler, A. Mosconi, Eric Pujade-Lauraine, C. Genestie, I. Ray-Coquard, P. Just","doi":"10.1136/ijgc-2024-esgo.633","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517833,"journal":{"name":"Poster and E-Posters","volume":"346 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"368 Can morphology and immune infiltration predict the HRD status in newly diagnosed high grade serous ovarian carcinoma? Lessons from the PAOLA-1/ENGOT-Ov25 Trial, a GINECO study\",\"authors\":\"Amel Kime, Guillaume Bataillon, Isabelle Treilleux, Céline Callens, Frédéric Selle, F. Heitz, S. Cinieri, Antonio González-Martín, Gerhard Bogner, Gabriel Lindahl, Gabriella Parma, I. Vergote, Takashi Matsumoto, C. Blonz, U. Canzler, A. Mosconi, Eric Pujade-Lauraine, C. Genestie, I. Ray-Coquard, P. Just\",\"doi\":\"10.1136/ijgc-2024-esgo.633\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":517833,\"journal\":{\"name\":\"Poster and E-Posters\",\"volume\":\"346 6\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Poster and E-Posters\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ijgc-2024-esgo.633\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Poster and E-Posters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-esgo.633","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
368 Can morphology and immune infiltration predict the HRD status in newly diagnosed high grade serous ovarian carcinoma? Lessons from the PAOLA-1/ENGOT-Ov25 Trial, a GINECO study